In view of the possible relation between pancreatic function and cystic fibrosis (CF) gene mutations, a detailed study on Italian patients was performed. Seventy pancreatic insufficient and 48 pancreatic sufficient patients were included after very accurate characterisation of their pancreatic and digestive function, ali performed in the same CF centre. The
features. About 15% of patients have sufficient pancreatic function for normal digestion and do not require pancreatic enzyme supplementation.
Genetic linkage studies have mapped the CF locus to chromosome 7.1-3 Several DNA markers, including KM19, XV2c, and MP6d9,4 5 are tightly linked to the CF locus. The CF gene has recently been identified and a deletion of three base pairs described,S8 which results in the loss of a phenylalanine residue at position 508 (A F508) of the putative product of the CF gene.
In North American CF patients, from 68%6 to 76%9 of the chromosomes show the deletion.
On the basis of extended DNA marker haplotype analysis of the CF locus, at least seven additional putative mutations have been indicated6 and the number of identified mutations has already increased beyond thisl' (CF Genetic Analysis Consortium, personal communication).
Determination of deletion F508 in pancreatic sufficient (PS) and pancreatic insufficient (PI) patients provided strong support for the hypothesis that pancreatic insufficiency is the result of the presence of two 'severe' alleles, deletion F508 belonging to this category.
Pancreatic sufficiency in turn has been attributed to the presence of at least one mild allele, dominant over the 'severe' ones. This hypothesis was derived from a limited number ( 64 were defined as pancreatic insufficient and 59 as pancreatic sufficient. Six of the latter had developed pancreatic insufficiency within the period of time from the first evaluation to the follow up (from 2-2 to 8 6 years), so they were transferred to the pancreatic insufficient group.
Two pancreatic sufficient patients did not present to follow up and were excluded from the study. Three subjects who did not have pancreatic enzyme replacement showed conflicting laboratory results, and were thought to have borderline pancreatic sufficiency, so were excluded. Therefore, the final total in the study included 48 confirmed pancreatic sufficient and 70 pancreatic insufficient patients. 
